Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia. The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 67
Healthy Volunteers: t
View:

• Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months

• BMI over 25

• age between 20 and 67

Locations
Other Locations
Taiwan
Min-Sheng General Hospital
RECRUITING
Taoyuan
Contact Information
Primary
Wei-Lei Lee, PhD
wjlee_obessurg_tw@yahoo.com.tw
88633179599
Time Frame
Start Date: 2014-03
Estimated Completion Date: 2034-12
Participants
Target number of participants: 1000
Treatments
Obese diabetic patients
Diabetic patients with BMI over 25 Age 20 to 67 Diabetes medically controlled at our center for at least six months
Related Therapeutic Areas
Sponsors
Leads: Min-Sheng General Hospital

This content was sourced from clinicaltrials.gov